Please review Interim Guideline 2 – Nebulisers.
Salbutamol may now be administered via nebuliser, although MDI / spacer is preferred.
Salbutamol MDI is considered a critical list item due to limited availability.
Crews should allow the patient to administer their own Salbutamol MDI via spacer wherever possible.
Allow the patient self-administer the Salbutamol; stand clear and wait a minute before approaching the patient.
If you have to use SJA supplied Salbutamol MDI, assess whether it can be reused and wipe with Clinell wipe after use. Discard the MDI if the patient is very unwell or highly symptomatic of infectious respiratory condition.
Advice regarding nebulisers is found in Section 2 of this advice. Both the officer and the patient should perform hand hygiene after use.
Crews may tolerate lower oxygen saturations in patients with infective respiratory symptoms prior to considering intervention, as the use of MDI’s may precipitate a cough. See Interim Guideline – Oxygenation for specifics regarding SpO2 tolerance.
Note: If administering St John supplied medication, crews are NOT to leave the remainder of the medication with the patient. This is a violation of the St John WA poisons licence and the Medicines and Poisons Act 2014.
The dosage/administration guidelines are as per Medication Protocol